scholarly journals First-line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-mutant Metastatic Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors

2018 ◽  
Vol 102 (3) ◽  
pp. e693
Author(s):  
X. Lu ◽  
J. Wang ◽  
C. Wang ◽  
N. Bi ◽  
Z. Zhou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Local Therapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Egfr Mutant

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

2019 ◽  
Vol 20 (2) ◽  
pp. 82-87 ◽  
Author(s):  
Sabrina Rossi ◽  
Luca Toschi ◽  
Giovanna Finocchiaro ◽  
Vincenzo Di Noia ◽  
Maria Bonomi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Exon 19 Deletion ◽  
Egfr Mutant ◽  
Exon 19

scholarly journals First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

2019 ◽  
Vol Volume 12 ◽  
pp. 1413-1421 ◽  
Author(s):  
Marscha S Holleman ◽  
Harm van Tinteren ◽  
Harry J M Groen ◽  
Maiwenn J Al ◽  
Carin A Uyl-de Groot
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Egfr Mutation ◽  
Meta Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document